Yue Tang

Dr. Yue Tang


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2016 in Molecular BioSystems
Verified
Journal Article
Closed access
PDF file
DZDong Zhang
Dong Zhang
YCYongchun Cui
Yongchun Cui
BLBin Li
Bin Li
XLXiaokang Luo
Xiaokang Luo
BLBo Li
Bo Li
YTYue Tang
Yue Tang
Cardiac fibrosis, as a pathological process, plays an important role in various cardiac diseases. microRNA-155 (miR-155) is one of the most important miRNAs, and previous studies have shown that it is a regulatory factor in various fibrotic diseases. However, the mechanism by which miR-155 affects myocardial fibrosis remains unclear. In this study, we aim to establish the biological function of miR-155 in myocardial fibrosis induced by diabetes in mice. We used normal C57BL/6 wild type (WT) and miR-155 knockout (KO) mice to establish the diabetic model by intraperitoneal injection of streptozotocin, and we utilized echocardiography to evaluate the cardiac function at 30 and 60 days post-modeling. Hematoxylin–eosin (HE) and sirius-red (SR) staining were used to evaluate the degree of myocardial lesions. Furthermore, we extracted cardiac fibroblasts (CFs) from the WT mice and transfected them with miR-155 inhibitors, mimics and negative control siRNAs to analyze the specific mechanism involved in the development of myocardial fibrosis. The results showed that miR-155 deficiency could prevent cardiac fibrosis induced by diabetes in mice and also that attenuated collagen synthesis is induced by high glucose (HG) in CFs. We found that miR-155 regulated cardiac fibrosis via the TGF-β1–Smad 2 signaling pathway. These findings suggest that miR-155 may be a therapeutic target for preventing cardiac fibrosis induced by diabetes.

23 July 2018 in Interactive CardioVascular and Thoracic Surgery
Verified
Journal Article
Closed access
XLXiaokang Luo
Xiaokang Luo
BLBo Li
Bo Li
DZDong Zhang
Dong Zhang
JZJiabao Zhu
Jiabao Zhu
LQLei Qi
Lei Qi
YTYue Tang
Yue Tang
OBJECTIVES The hybrid ablation via transdiaphragmatic approach (convergent procedure) is a newly emerging treatment for atrial fibrillation. However, the results reported by different centres are controversial. The purpose of this study is to investigate the efficacy and safety of the convergent procedure by performing a meta-analysis. METHODS We searched the PubMed, EMBASE and Cochrane Library databases and calculated the pooled estimates. The I-2 test, (2) test and meta-regression analysis were performed to evaluate the heterogeneity. Funnel plots were used to detect publication bias. Trim-and-fill method was performed to identify possible asymmetry. RESULTS In total, 6 observational studies involving 478 patients were identified for the final analysis. The pooled estimated rate of sinus rhythm maintenance within 12months was 84.3% ((2)=14.69, P=0.012). The meta-regression analysis showed that the mean duration of atrial fibrillation affected the heterogeneity. Two additional studies need to be trimmed according to the trim-and-fill method. The pooled estimate was 60.2% after filling. The overall complication rate was 9.0%, and the mortality rate was 1.7%. CONCLUSIONS The efficacy of the convergent atrial fibrillation procedure is relatively satisfactory. However, the overall complication incidence is relatively high, and the procedural mortality rate is unacceptable.

1 April 2016 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
HZHong Zhang
Hong Zhang
YCYong-Chun Cui
Yong-Chun Cui
KLKai Li
Kai Li
BYBai-Qing Yang
Bai-Qing Yang
XLXiao-Peng Liu
Xiao-Peng Liu
YTYue Tang
Yue Tang

29 April 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
DZDong Zhang
Dong Zhang
BLBo Li
Bo Li
BLBin Li
Bin Li
YTYue Tang
Yue Tang
SIRT1 (silent information regulator 1) is a histone deacetylase. It can sense the energy level in cells and delay cell senescence, leading to resistance to external stress and improving metabolism. Mitral regurgitation (MR) is a common disease in cardiac surgery. However, there are no previous studies on SIRT1 and left atrial fibrosis caused by MR. In this study, we aimed to explore the regulatory effect of SIRT1 on left atrial fibrosis induced by MR. We used Guizhou miniature pigs to establish an MR model and a sham operation model after anaesthesia induction and respiratory intubation, and these model animals were followed for 30 months after the surgery. The differential distribution and expression of SIRT1 and collagen I in the left atrium was determined by immunofluorescence and Western blotting. Furthermore, we treated NIH3T3 fibroblasts (CFs) with resveratrol and Angiotensin II (Ang II) to analyse the specific mechanism involved in the development of myocardial fibrosis. The results showed that the MR model was successfully constructed. There were 8 pigs in the MR group and 6 pigs in the control group. In both the animal experiments and the cell experiments, the expression of collagen I in the MR group was increased significantly compared to that in the control group, while the expression of SIRT1 was decreased.

1 May 2019 in Cardiovascular Pathology
Verified
Journal Article
Closed access
BLBo Li
Bo Li
FLFuliang Luo
Fuliang Luo
XLXiaokang Luo
Xiaokang Luo
BLBin Li
Bin Li
LQLei Qi
Lei Qi
YTYue Tang
Yue Tang

8 May 2016 in Journal of Surgical Education
Verified
Journal Article
Closed access
PDF file
XLXiaopeng Liu
Xiaopeng Liu
YYYan Yang
Yan Yang
QMQiang Meng
Qiang Meng
JSJiakang Sun
Jiakang Sun
FLFuliang Luo
Fuliang Luo
YTYue Tang
Yue Tang